Vergoeding 2017-2021 voor ATC-subgroep C09CA : Angiotensine-ii-antagonisten

  • Raming voor de totale Zvw-populatie
  2017 2018 2019 2020 2021
C09CA01 Losartan (Cozaar ®) 2.564.900 3.059.100 5.498.300 5.677.800 4.905.100
C09CA02 Eprosartan (Teveten ®) 378.180 363.030 113.450 48.291 52.312
C09CA03 Valsartan (Diovan ®) 3.226.000 3.565.200 2.702.600 2.551.800 2.970.600
C09CA04 Irbesartan (Aprovel ®) 2.529.500 2.643.100 4.278.100 4.182.000 3.744.600
C09CA06 Candesartan (Atacand ®) 1.086.200 1.209.900 1.777.100 2.006.600 2.004.300
C09CA07 Telmisartan (Micardis ®) 798.050 776.110 1.284.300 1.440.600 1.224.600
C09CA08 Olmesartan (Olmetec ®) 1.849.000 692.860 582.140 825.340 651.380
Totaal 12.431.830 12.309.300 16.235.990 16.732.431 15.552.892